Tak Yiu Cheng
Director of Finance/CFO bij GOLDEN ALLY LIFETECH GROUP, INC.
Vermogen: 725 000 $ op 31-07-2023
Profiel
Tak Yiu Cheng is currently an Executive Director at Innovative Pharmaceutical Biotech Ltd.
and a Chief Financial Officer at Golden Ally Lifetech Group, Inc. Previously, he worked as an Executive Director at Value Convergence Holdings Ltd.
in 2021.
He also worked as a Research Analyst at Deutsche Bank AG (Hong Kong) and as a Vice President at T.
Rowe Price Hong Kong Ltd.
Mr. Cheng completed his undergraduate degree at the University of Hong Kong.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
31-03-2023 | 5 000 000 ( 0.07% ) | 725 000 $ | 31-07-2023 |
Actieve functies van Tak Yiu Cheng
Bedrijven | Functie | Begin |
---|---|---|
INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED | Director/Board Member | 04-07-2023 |
GOLDEN ALLY LIFETECH GROUP, INC. | Director of Finance/CFO | - |
Eerdere bekende functies van Tak Yiu Cheng
Bedrijven | Functie | Einde |
---|---|---|
VALUE CONVERGENCE HOLDINGS LIMITED | Director/Board Member | 24-05-2021 |
T. Rowe Price Hong Kong Ltd.
T. Rowe Price Hong Kong Ltd. Investment ManagersFinance T. Rowe Price Hong Kong Ltd. (do-business-as Price Hong Kong), is an asset management firm headquartered in Hong Kong. The firm was founded in 1987 and is a wholly owned subsidiary of T. Rowe Price International Ltd., ultimately held by T. Rowe Price Group, Inc. (NYSE: TROW, NASDAQ: TROW) in the US. Price Hong Kong provides a full range of equity, fixed income, and asset allocation strategies across multiple sectors, styles, and regions to institutional investors. They are a signatory to the UN Principles for Responsible Investment (UNPRI). | Analyst-Equity | - |
Deutsche Bank AG (Hong Kong)
Deutsche Bank AG (Hong Kong) Investment Banks/BrokersFinance Part of Deutsche Bank AG, Deutsche Bank AG (Hong Kong) is a financial institution that has been connecting worlds for 65 years. The private company is based in Hong Kong, Hong Kong, and serves as the hub for corporate and commercial clients. The company's asset management division, DWS, is a market leader in Hong Kong with a broad product offering. Its corporate bank division is an established market leader in transaction banking, with a presence in 60 countries, including an extensive footprint in HK. The investment bank provides strategic advice to corporate and institutional clients, focusing on the bank’s traditional strengths in financing, advisory, fixed income, and currencies, together with a focused equity capital markets business. The private bank focuses on private customers across all segments as well as business clients, and in HK, this division is represented by a highly competitive wealth manager. The Chinese company was founded in 1958, and its CEO is Werner Steinmüller. | Analyst-Equity | - |
Opleiding van Tak Yiu Cheng
University of Hong Kong | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED | Retail Trade |
VALUE CONVERGENCE HOLDINGS LIMITED | Finance |
Bedrijven in privébezit | 3 |
---|---|
Golden Ally Lifetech Group, Inc. | |
Deutsche Bank AG (Hong Kong)
Deutsche Bank AG (Hong Kong) Investment Banks/BrokersFinance Part of Deutsche Bank AG, Deutsche Bank AG (Hong Kong) is a financial institution that has been connecting worlds for 65 years. The private company is based in Hong Kong, Hong Kong, and serves as the hub for corporate and commercial clients. The company's asset management division, DWS, is a market leader in Hong Kong with a broad product offering. Its corporate bank division is an established market leader in transaction banking, with a presence in 60 countries, including an extensive footprint in HK. The investment bank provides strategic advice to corporate and institutional clients, focusing on the bank’s traditional strengths in financing, advisory, fixed income, and currencies, together with a focused equity capital markets business. The private bank focuses on private customers across all segments as well as business clients, and in HK, this division is represented by a highly competitive wealth manager. The Chinese company was founded in 1958, and its CEO is Werner Steinmüller. | Finance |
T. Rowe Price Hong Kong Ltd.
T. Rowe Price Hong Kong Ltd. Investment ManagersFinance T. Rowe Price Hong Kong Ltd. (do-business-as Price Hong Kong), is an asset management firm headquartered in Hong Kong. The firm was founded in 1987 and is a wholly owned subsidiary of T. Rowe Price International Ltd., ultimately held by T. Rowe Price Group, Inc. (NYSE: TROW, NASDAQ: TROW) in the US. Price Hong Kong provides a full range of equity, fixed income, and asset allocation strategies across multiple sectors, styles, and regions to institutional investors. They are a signatory to the UN Principles for Responsible Investment (UNPRI). | Finance |